Old Web
English
Sign In
Acemap
>
authorDetail
>
Li-Jun Dai
Li-Jun Dai
Guangzhou Medical University
Naftopidil
Chemistry
Hyperplasia
Prostate
Internal medicine
4
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Study of Multiple Diagnosis Models of Human Prostate Cancer Based on Taylor Database by Artificial Neural Networks.
2020
Journal of The Chinese Medical Association
Funeng Jiang
Li-Jun Dai
Yong-ding Wu
Sheng-bang Yang
Yu-xiang Liang
Xin Zhang
Cui-yun Zou
Ren-Qiang He
Xiao-Ming Xu
Weide Zhong
Show All
Source
Cite
Save
Citations (0)
Increasing of FKBP9 can predict poor prognosis in patients with prostate cancer
2019
Pathology Research and Practice
Funeng Jiang
Li-Jun Dai
Sheng-bang Yang
Yong-ding Wu
Yu-xiang Liang
Xiao-Li Yin
Cui-yun Zou
Weide Zhong
Show All
Source
Cite
Save
Citations (3)
Inhibitory effect of α1D/1A antagonist 2-(1H-indol-3-yl)-N-[3-(4-(2-methoxyphenyl) piperazinyl) propyl] acetamide on estrogen/androgen-induced rat benign prostatic hyperplasia model in vivo
2019
European Journal of Pharmacology
Qi-Meng Liu
Qing Xiao
Xiang Zhu
Kai-feng Chen
Xia-Wen Liu
Ru-chao Jiang
Dan Wu
Jun-min Shi
Li-Jun Dai
Jun–jun Huang
Show All
Source
Cite
Save
Citations (2)
Novel naftopidil derivatives containing methyl phenylacetate and their blocking effects on α1D/1A-adrenoreceptor subtypes
2018
Bioorganic & Medicinal Chemistry Letters
Junjun Huang
Zhihan Zhang
Fei He
Xiawen Liu
Xingjie Xu
Li-Jun Dai
Qi-Meng Liu
Mu Yuan
Show All
Source
Cite
Save
Citations (3)
1